Ascend Recalls Olmesartan Medoxomil Tablets Due to cGMP Deviations
Ascend Laboratories is recalling 192 bottles of Olmesartan Medoxomil 20 mg tablets because they were released in error with an alternate API source before approval.
- Product
- OLMESARTAN MEDOXOMIL — OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)
- Category
- Drug
- Distribution
- Distributed nationwide